Veracyte Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Veracyte, Inc (VCYT) PT Raised to $55 at Needham & Company
July 30, 2021 6:28 AM EDTNeedham & Company analyst Mike Matson raised the price target on Veracyte, Inc (NASDAQ: VCYT) to $55.00 (from $54.00) while maintaining a Buy rating.
The analyst commented, "VCYT's 2Q21 revenue and EPS beat consensus. Organic revenue growth improved to 77% in 2Q21 from 5.7% in 1Q21 as... More
Veracyte (VCYT) Tops Q2 EPS by 12c
July 29, 2021 4:26 PM EDTVeracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $55.1 million versus the consensus estimate of $48.06 million.
GUIDANCE:
Veracyte sees FY2021 revenue of $200-208 million, versus the consensus of $197.9... More
